<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00830557</url>
  </required_header>
  <id_info>
    <org_study_id>354-06</org_study_id>
    <secondary_id>P50CA102701-08</secondary_id>
    <secondary_id>CDR0000613100</secondary_id>
    <nct_id>NCT00830557</nct_id>
  </id_info>
  <brief_title>Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders</brief_title>
  <official_title>Biospecimen Resource for Pancreas Research, a Data &amp; Tissue Bank (Also Known as a Bio-repository, Bio-bank, Data &amp; Tissue Database, Data &amp; Tissue Registry, Etc.) to Help Advance Research in Pancreas Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: Gathering medical information and collecting and storing samples of blood and&#xD;
      tissue to test in the laboratory may help doctors develop better ways to screen people at&#xD;
      risk for pancreatic cancer or other pancreatic disorders in the future.&#xD;
&#xD;
      PURPOSE: This clinical trial is collecting medical information and tissue samples from&#xD;
      patients with pancreatic cancer or other pancreatic disorders.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:&#xD;
&#xD;
      Primary&#xD;
&#xD;
        -  To collect clinical data and family histories and blood and/or tissue samples from&#xD;
           patients diagnosed with pancreatic diseases, including pancreatic cancer, for use in&#xD;
           future studies.&#xD;
&#xD;
        -  To collect information regarding food preparation and intake in these patients.&#xD;
&#xD;
      Secondary&#xD;
&#xD;
        -  To make available to researchers medical data and biospecimens to enable them to develop&#xD;
           better ways to screen people at risk for pancreatic conditions, including pancreatic&#xD;
           cancer.&#xD;
&#xD;
        -  To investigate genes or substances that increase susceptibility of developing pancreatic&#xD;
           conditions.&#xD;
&#xD;
        -  To find agents that may help prevent, treat, or cure these conditions.&#xD;
&#xD;
        -  To learn whether inherited factors increase the risk of pancreatic diseases, pancreatic&#xD;
           cancer, or other cancers.&#xD;
&#xD;
      OUTLINE: This is a multicenter study.&#xD;
&#xD;
      Patients complete two 1-hour surveys assessing health, clinical and family history of&#xD;
      pancreatic conditions including cancer, and food preparation and intake. Patients also&#xD;
      complete a 15- to 30-minute follow up survey at 6 months and 1 year to assess health, health&#xD;
      practices, and family history. A review of the patient's medical information is obtained from&#xD;
      the medical record.&#xD;
&#xD;
      Blood samples are collected for future research studies. Oral cells and stool samples may&#xD;
      also be collected for future studies.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2000</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Collection of clinical data, health and family histories by survey</measure>
    <time_frame>baseline enrollment, 6 months, 12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Collection of blood and/or tissue, fecal and oral specimens</measure>
    <time_frame>baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Collection of information regarding food preparation and intake by survey</measure>
    <time_frame>baseline</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">7500</enrollment>
  <condition>Islet Cell Tumor</condition>
  <condition>Pancreatic Cancer</condition>
  <condition>Pancreatic Disease</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>medical chart review</intervention_name>
    <description>baseline, 12 month and 36 months</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>survey administration</intervention_name>
    <description>baseline, 6 month, 12 month</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>biospecimen collection</intervention_name>
    <description>baseline</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Two 10mL plasma tubes, two 10mL serum tubes and one 10mL heparin tube collected. DNA&#xD;
      extracted from lymphocytes. Possible saliva collection for DNA extraction. Waste tissue from&#xD;
      prior surgery may be collected. Stool samples may be collected.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Pancreas disease patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:&#xD;
&#xD;
          -  Diagnosis or suspicion of at least one of the following:&#xD;
&#xD;
               -  Pancreatic cancer&#xD;
&#xD;
               -  Pancreatic mass&#xD;
&#xD;
               -  Islet cell tumor&#xD;
&#xD;
               -  Intraductal papillary mucinous neoplasms (IPMN)&#xD;
&#xD;
               -  Hereditary pancreatitis&#xD;
&#xD;
        PATIENT CHARACTERISTICS:&#xD;
&#xD;
          -  Able to understand and read English&#xD;
&#xD;
          -  Mentally competent and able to provide informed consent&#xD;
&#xD;
          -  Has not donated blood within the past 8 weeks&#xD;
&#xD;
        PRIOR CONCURRENT THERAPY:&#xD;
&#xD;
          -  At least 7 days since prior blood transfusion&#xD;
&#xD;
          -  At least 7 days since prior surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>120 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gloria M. Petersen, PhD, FACMG</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Casi Bell</last_name>
    <phone>1-800-914-7962</phone>
    <email>pancreas@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bridget Rathbun</last_name>
    <phone>1-800-914-7962</phone>
    <email>pancreas@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic Cancer Center</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - All Mayo Clinic Locations</last_name>
      <phone>507-538-7623</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 27, 2009</study_first_submitted>
  <study_first_submitted_qc>January 27, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2009</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Gloria M. Petersen</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>recurrent pancreatic cancer</keyword>
  <keyword>stage I pancreatic cancer</keyword>
  <keyword>stage II pancreatic cancer</keyword>
  <keyword>stage III pancreatic cancer</keyword>
  <keyword>stage IV pancreatic cancer</keyword>
  <keyword>recurrent islet cell carcinoma</keyword>
  <keyword>pancreatic alpha cell carcinoma</keyword>
  <keyword>pancreatic beta islet cell carcinoma</keyword>
  <keyword>pancreatic delta cell carcinoma</keyword>
  <keyword>pancreatic G-cell carcinoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
    <mesh_term>Adenoma, Islet Cell</mesh_term>
    <mesh_term>Pancreatic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

